Article
Synthesis, biological evaluation and in silico modeling of novel pan-genotypic NS5A inhibitors.
Bioorganic & medicinal chemistry - 15 Oct 2020
Ivashchenko Andrey A, Ivanenkov Yan A, Aladinskiy Vladimir A, Karapetian Ruben N, Koryakova Angela G, Ryakhovskiy Alexey A, Mitkin Oleg D, Kravchenko Dmitry V, Savchuk Nikolai P, Zagribelnyy Bogdan A, Ivashchenko Alexander V
Abstract excerpt
A series of novel small-molecule pan-genotypic hepatitis C virus (HCV) NS5A inhibitors with picomolar activity containing 2-[(2S)-pyrrolidin-2-yl]-5-[4-(4-{2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl}buta-1,3-diyn-1-yl)phenyl]-1H-imidazole core was designed based on molecular modeling study and SAR analysis. The constructed in silico model and docking study provide a deep insight into the binding mode of this type...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.